05.07.2013 Views

Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

Graphique 1 - Faculté de Médecine et de Pharmacie de Fès

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

symptomatic tumor (87.5%), absence of histological evi<strong>de</strong>nce of benign tumor<br />

preoperatively because the fat component does not always eliminate renal cancer.<br />

For the eighth patient, monitoring of clinical and laboratory evolution of the<br />

tumor was indicated, but was unfortunately lost sight.<br />

The pathological analysis showed triphasic AML in all cases. In two patients<br />

the pathology report showed the presence of necrotic alterations (Comment No. 3<br />

and 4), one even had the invasion of the capsule and perirenal fat. Athird patient<br />

had an infiltration of the right renal vein (Comment No. 5). In another patient (case<br />

No. 2), histological study had revealed asecond tumor associated with AML in the<br />

same kidney and correspon<strong>de</strong>d to the renal cell carcinoma.<br />

AML is a rare benign tumor that usually occurs in women. The presumed<br />

diagnosis based on CT, the positive diagnosis is histological. Its management should<br />

be conservative, to preserve the renal function. But the use of total nephrectomy is<br />

som<strong>et</strong>imes unavoidable. The therapeutic prospects of AML are mini-ablative surgery<br />

(cryoablation and radiofrequency) and medical treatment with rapamycin.<br />

156

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!